1322055-96-8

Basic information

• Product Name: N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea
• Synonyms: N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea
• CAS NO: 1322055-96-8
• Molecular Weight: 575.727
• Mol File: 1322055-96-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea(CAS DataBase Reference)
• NIST Chemistry Reference: N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea(1322055-96-8)
• EPA Substance Registry System: N-[1-(1-adamantyl)methyl-5-(2-diethylaminoethyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea(1322055-96-8)

Safety Data

• Hazardous Substances Data: 1322055-96-8(Hazardous Substances Data)

Upstream product

• 163617-85-4 N-(1-adamantanecarbonyl)-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine 
• 163617-86-5 N-(1-adamantyl)methyl-N'-(4-methoxyphenyl)methyl-1,2-phenylenediamine 
• 163617-87-6 1-(1-adamantyl)methyl-2,4-dioxo-5-(4-methoxyphenyl)methyl-3-phenylhydrazono-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 2094-72-6 1-Adamantanecarbonyl chloride 
• 5729-16-8 N-(4-methoxy-benzyl)-benzene-1,2-diamine 
• 163617-89-8 1-(1-adamantyl)methyl-3-amino-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 163617-88-7 1-(1-adamantyl)methyl-3-amino-2,4-dioxo-5-(4-methoxyphenyl)methyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine 
• 1322055-75-3 N-[1-(1-adamantyl)methyl-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl]-N'-(4-fluorophenyl)urea 
• 869-24-9 2-chloro-N,N-diethylethylamine hydrochloride 

Relevant articles and documents

Synthesis and structure-activity relationship of new 1,5-dialkyl-1,5- benzodiazepines as cholecystokinin-2 receptor antagonists

This article deals with the synthesis and the activities of some 1,5-dialkyl-3-arylureido-1,5-benzodiazepin-2,4-diones which were prepared as potential CCK2 antagonists, with the intention to find a possible follow up of our lead compound GV150013, showin